Wene Wei
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Heat shock proteins research
- Extracellular vesicles in disease
Papers in
-
- Circular RNAs in diseases 3
- RNA modifications and cancer 3
- Extracellular vesicles in disease 3
- Heat shock proteins research 2
- PI3K/AKT/mTOR signaling in cancer 1
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 6
- Co-authors
- Litu Zhang (14 shared papers)Shufang Ning (14 shared papers)Jilin Li (10 shared papers)Haizhou Liu (10 shared papers)Jian‐Hong Zhong (4 shared papers)Xianwei Mo (3 shared papers)Jiansi Chen (3 shared papers)Kaisheng Liu (2 shared papers)
- Journals
- Frontiers in Cell and Developmental Biology (2 papers)Frontiers in Molecular Biosciences (2 papers)Frontiers in Bioengineering and Biotechnology (1 paper)PLoS ONE (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaTajikistan
In The Last Decade
Wene Wei
19 papers receiving 414 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 175
- Molecular Biology 221
- Oncology 67
- Pulmonary and Respiratory Medicine 51
- Pharmacology 11
Countries citing papers authored by Wene Wei
This map shows the geographic impact of Wene Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wene Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wene Wei more than expected).
Fields of papers citing papers by Wene Wei
This network shows the impact of papers produced by Wene Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wene Wei. The network helps show where Wene Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Wene Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 81 | |
| 2 | 2021 | 55 | |
| 3 | 2019 | 46 | |
| 4 | 2019 | 44 | |
| 5 | 2020 | 33 | |
| 6 | 2021 | 29 | |
| 7 | 2016 | 28 | |
| 8 | 2016 | 17 | |
| 9 | 2016 | 15 | |
| 10 | 2021 | 12 | |
| 11 | 2023 | 11 | |
| 12 | 2022 | 11 | |
| 13 | 2015 | 11 | |
| 14 | 2021 | 8 | |
| 15 | Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features. | 2014 | 6 |
| 16 | 2025 | 5 | |
| 17 | 2023 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2023 | 2 |
About Wene Wei
Wene Wei is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 19 papers that have together received 420 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (3 papers), RNA modifications and cancer (3 papers), Extracellular vesicles in disease (3 papers), Heat shock proteins research (2 papers), PI3K/AKT/mTOR signaling in cancer (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). The work is most often cited by research in Cancer Research (175 citations), Molecular Biology (221 citations), Oncology (67 citations), Pulmonary and Respiratory Medicine (51 citations) and Pharmacology (11 citations). Wene Wei has collaborated with scholars based in China and Tajikistan. Frequent co-authors include Litu Zhang, Shufang Ning, Jilin Li, Haizhou Liu, Jian‐Hong Zhong, Xianwei Mo, Jiansi Chen, Kaisheng Liu, Bingbing Hou and Yuxuan Xie. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Frontiers in Molecular Biosciences, Frontiers in Bioengineering and Biotechnology, PLoS ONE and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.